Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2810115 | Trends in Endocrinology & Metabolism | 2016 | 4 Pages |
Abstract
Glucagon-like peptide (GLP)-1 receptor agonists enhance insulin secretion and may improve pancreatic islet cell function. However, GLP-1 receptor (GLP-1R) agonist treatment may have more complex, and sometimes deleterious, effects on beta cells. We discuss the concepts of beta cell protection versus exhaustion for different GLP-1R agonists based on recent data.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Daniël H van Raalte, C. Bruce Verchere,